Rationing the access to high cost medicines in developing countries

Developing World Bioethics 9 (2):ii-iii (2009)
  Copy   BIBTEX

Abstract

No Abstract

Categories

Keywords

Reprint years

DOI

10.1111/j.1471-8847.2009.00260.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,611

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Organizational ethics and the high cost of medicines.Philip J. Candilis - 2000 - HEC Forum 12 (4):303-310.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Improving access to essential medicines: How health concerns can be prioritised in the global governance system.Devi Sridhar - 2008 - Public Health Ethics 1 (2):83-88.
Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation.Rudolf V. Van Puymbroeck - 2010 - Journal of Law, Medicine and Ethics 38 (3):520-549.
Pharmaceutical innovation and the burden of disease in developing and developed countries.Frank R. Lichtenberg - 2005 - Journal of Medicine and Philosophy 30 (6):663 – 690.
Too Poor To Treat? The Complex Ethics of Cost-Effective Tobacco Policy in the Developing World.A. Bitton & N. Eyal - 2011 - Public Health Ethics 4 (2):109-120.
Have developed countries escaped the curse of distance?Herve Boulhol & Alain de Serres - unknown

Analytics

Added to PP
2009-07-24

Downloads
33 (#488,740)

6 months
2 (#1,206,551)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references